Clinical Study
Testing the Device XEN Glaucoma Treatment System for People with Glaucoma
Glaucoma is high pressure inside the eye that can lead to blindness. This study will test a device XEN Glaucoma Treatment System to treat people with this disease. The study wants to see if the device will help people with this disease and is safe. People in the study will attend pre-study treatment, surgery, and post-surgery treatment. Being in the study requires at least 11 study visits at the clinic for about 14 months. Medical tests will be done during the study to track the health of participants.
For more information contact:
Kelliann Ordonez
kelliann.ordonez@hsc.utah.edu
(801)585-7975
IRB#: IRB_00157451
| PI: Craig Chaya
| Department: OPHTHALMOLOGY AND VISUAL SCIENCE
| Approval Date: 2023-04-19 06:00:00
Study Categories: Ophthalmic Studies
| Specialties: Ophthalmology
Who can participate?
Gender: All
Age: Over 18 years old
Volunteers: Volunteers with special conditions
Location: In Person
Inclusion Criteria:
- Age 45 years and older
- Diagnosis of Glaucoma in the eye being studied
- Glaucoma of the study eye with specific criteria
- Participants of childbearing age must use specific birth control
- Able to attend in person at the study clinic
Exclusion Criteria:
- Pregnant
- Receiving treatment of any other study drug or device 30 days before participation
- History of allergic reaction or sensitivity to any part of the treatment
- History of specific eye surgeries
Will I be paid for my time?
Yes